000			01852 a2200541 4500
005			20250513175517.0
264		0	_c19990623
008			199906s 0 0 eng d
022			_a0172-8172
024	7		_a10.1007/s002960050071 _2doi
040			_aNLM _beng _cNLM
100	1		_aArborelius, M
245	0	0	_aGly-X-Y repeat sequences in the treatment of active rheumatoid arthritis. _h[electronic resource]
260			_bRheumatology international _c1999
300			_a129-35 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnalysis of Variance
650	0	4	_aArthritis, Rheumatoid _xdiagnosis
650	0	4	_aCalcium-Binding Proteins _xadministration & dosage
650	0	4	_aCollagen _xadministration & dosage
650	0	4	_aCollagen Type II
650	0	4	_aCross-Over Studies
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGelatin _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPain Measurement
650	0	4	_aPilot Projects
650	0	4	_aProtein Conformation
650	0	4	_aRange of Motion, Articular _xdrug effects
650	0	4	_aReference Values
650	0	4	_aRepetitive Sequences, Nucleic Acid
650	0	4	_aSeverity of Illness Index
650	0	4	_aStructure-Activity Relationship
650	0	4	_aTreatment Outcome
700	1		_aKonttinen, Y T
700	1		_aNordström, D C
700	1		_aSolovieva, S A
773	0		_tRheumatology international _gvol. 18 _gno. 4 _gp. 129-35
856	4	0	_uhttps://doi.org/10.1007/s002960050071 _zAvailable from publisher's website
999			_c10179997 _d10179997